---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-014332"
form_type: "8-K"
ticker: "CTXR"
cik: "0001506251"
company_name: "Citius Pharmaceuticals, Inc."
filed_at: "2024-02-15T23:59:59+00:00"
generated_at: "2026-06-06T01:10:26.231494+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Citius Pharma Q1 net loss $9.2M; cash runway through Aug 2024

## Summary
- Net loss of $9.2M ($0.06 per share) compared to loss of $3.6M ($0.02 per share) in prior year.
- Cash and equivalents $20.3M as of Dec 31, 2023; runway expected through August 2024.
- LYMPHIR BLA resubmitted to FDA; awaiting PDUFA date; merger of oncology subsidiary with TenX (TENK) expected H1 2024.
- Completed enrollment in Mino-Lok Phase 3 trial; topline results expected in Q2 2024.
- R&D expenses $2.6M (down from $3.4M); G&A expenses $3.7M (up from $2.6M).

## SEC filing metadata
- accession: 0001213900-24-014332
- form_type: 8-K
- ticker: CTXR
- cik: 0001506251
- company_name: Citius Pharmaceuticals, Inc.
- filed_at: 2024-02-15T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506251/000121390024014332/0001213900-24-014332-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506251/000121390024014332/ea193774-8k_citius.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-014332
- JSON: https://secwatch.observer/filing/0001213900-24-014332.json
- Plain text: https://secwatch.observer/filing/0001213900-24-014332.txt

## Key facts
- Earnings Releases
  Citius Pharmaceuticals, Inc. reported first quarter of fiscal 2024 results: net income $9.2 million, or ($0.06) per share, EPS ($0.06) per share.
  - Period: first quarter of fiscal 2024
  - Net income: $9.2 million, or ($0.06) per share
  - EPS: ($0.06) per share
  - Result: reported results
  source text: On February 14, 2024, we issued a press release announcing our results of operations for the first quarter of fiscal 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506251/000121390024014332/0001213900-24-014332-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.